Pentagon Offers Antheia $80 Million to Make Drug Ingredients in U.S.
The Pentagon's Office of Strategic Capital has offered biosynthesis firm Antheia an $80 million conditional loan to make drug ingredients in America.
Office of Strategic Capital
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- Meta, Tesla and SpaceX Face Wall Street’s Big AI Test After a Brutal Week
- FDA Cleared an AI Breast Cancer Risk Score. Here’s What’s Unproven
- 10 Miles Spared Guam as Super Typhoon Champi Hit 150 mph Winds
- $15 Million on 855 Screens: Holmes Doc Stuns the Box Office